Net Profit Margin: -1371.51%

Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the net profit margin high or low?

The net profit margin of -1371.51% is 609% below its 5-year average of -193.31%, near the high end of its 5-year range (-10140324.65%–0.00%).

121.71% below its 12-month average of -618.59%.

CBIO Net Profit Margin Metrics

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin = Net Income / Revenue

Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Net Profit Margin FAQ

What is the net profit margin for Crescent Biopharma, Inc. (CBIO)?

The net profit margin for CBIO stock is -1371.51%.

Is Crescent Biopharma, Inc.'s net profit margin high or low?

The net profit margin of -1371.51% is 609% below its 5-year average of -193.31%, near the high end of its 5-year range (-10140324.65%–0.00%).

What is the TTM average net profit margin for Crescent Biopharma, Inc. (CBIO)?

The TTM average net profit margin for CBIO stock is -618.59%.

What is the 3Y average net profit margin for Crescent Biopharma, Inc. (CBIO)?

The 3Y average net profit margin for CBIO stock is 0.00%.

What is the 5Y average net profit margin for Crescent Biopharma, Inc. (CBIO)?

The 5Y average net profit margin for CBIO stock is -193.31%.

What is the 10Y average net profit margin for Crescent Biopharma, Inc. (CBIO)?

The 10Y average net profit margin for CBIO stock is -110.97%.

What is the 15Y average net profit margin for Crescent Biopharma, Inc. (CBIO)?

The 15Y average net profit margin for CBIO stock is -127.73%.

Related Metrics